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e provide the ﬁrst characterization of a novel
signaling adapter, Nesca, in neurotrophic signal
transduction. Nesca contains a RUN domain, a
WW domain, a leucine zipper, a carboxyl-terminal SH3
domain, and several proline-rich regions. Nesca is highly
expressed in the brain, is serine phosphorylated, and
mobilizes from the cytoplasm to the nuclear membrane in
response to neurotrophin, but not epidermal growth factor,
stimulation in a MEK-dependent process. Overexpression
studies in PC12 cells indicate that Nesca facilitates neuro-
trophin-dependent neurite outgrowth at nonsaturating doses
W
 
of nerve growth factor (NGF). Similarly, short interfering
RNA studies signiﬁcantly reduce NGF-dependent neurito-
genesis in PC12 cells. Mutational analyses demonstrate
that the RUN domain is an important structural determinant
for the nuclear translocation of Nesca and that the nuclear
redistribution of Nesca is essential to its neurite outgrowth-
promoting properties. Collectively, these works provide the
ﬁrst functional characterization of Nesca in the context of
neurotrophin signaling and suggest that Nesca serves a
novel, nuclear-dependent role in neurotrophin-dependent
neurite outgrowth.
 
Introduction
 
Ligand activation of the NGF receptor tyrosine kinase, trkA,
results in the downstream activation of several signaling
proteins including Ras, MAPK, phosphatidylinositol-3 kinase
(PI-3 kinase), Raf-1, FRS2, Shc, and AKT (Meakin, 2000;
Huang and Reichardt, 2003). As a consequence of the acti-
vation of such a varied array of signaling intermediates, trkA
plays a vital role in a variety of cellular processes such as the
survival and development of sympathetic neurons as well as
the pain and temperature sensitive sensory neurons of the
peripheral nervous system (Meakin, 2000; Huang and
Reichardt, 2003). Given the diverse roles that trkA plays in
regulating neuronal development and function, an under-
standing of the complex intracellular signal transduction
pathways stimulated after trkA activation is highly relevant.
Incumbent upon our understanding of how trkA functions
is an understanding of how the kinase and downstream targets
are regulated and how this translates into changes in gene
expression and cell function. Several signaling proteins bind
directly to activated trkA, including Shc, phospholipase C
 
 
 
-1
(PLC
 
 
 
-1), rAPS, SH2B, FRS2, Grb2 (MacDonald et al., 2000;
Meakin, 2000; Qian and Ginty, 2001; Huang and Reichardt,
2003), the Csk homologous kinase (CHK; Yamashita et
al., 1999), and the atypical PKC–interacting protein p62
(Wooten et al., 2001a). Many of these proteins are recruited
into signaling complexes and activate downstream targets
such as MAPK, whereas others act as scaffold proteins to
stabilize active trkA complexes. Activated trkA also binds to the
intermediate filament proteins peripherin and 
 
 
 
-internexin
(MacDonald et al., 1999), which may also have scaffolding
implications, by coupling trkA to the cytoskeleton.
In neuroendocrine rat pheochromocytoma (PC12) cells,
NGF induces a differentiative response, whereas in non-
neuronal cells, the response is proliferative (Meakin, 2000).
Although the regulatory elements governing these diverse
responses are not completely understood, several pathways
have been implicated. Included among these pathways are
the tyrosine phosphorylation and recruitment of FRS2
(Meakin et al., 1999; Ong et al., 2000; Zeng and Meakin,
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2002), prolonged activation of MAPK (York et al., 1998;
Kao et al., 2001; Wu et al., 2001; Yasui et al., 2001), activa-
tion of p38 MAPK (Morooka and Nishida, 1998; Iwasaki et
al., 1999), and atypical PKC-mediated activation of NF-
 
 
 
B
(Wooten et al., 2001a,b).
One recently described putative signaling adapter pro-
tein is Nesca (new molecule containing an SH3 domain at
the carboxyl terminus; Matsuda et al., 2000). Although
the signaling capacity of Nesca has yet to be shown, its
molecular architecture is highly reminiscent of a signaling
adapter protein. In addition to an SH3 domain, Nesca
contains a putative WW domain, a leucine zipper, and
several distinct proline-rich regions that may serve to re-
cruit other SH3 domain–containing proteins (Fig. 1 A;
Kay et al., 2000). Nesca also contains a newly described
RUN domain spanning 144 amino acids from 53D–197E
(Callebaut et al., 2001). Although the precise role of the
RUN domain remains to be determined, many RUN
domain–containing proteins are involved in Ras-like
GTPase signaling (Callebaut et al., 2001; Mari et al., 2001;
Yang et al., 2002).
Herein, we provide the first characterization of a role for
Nesca in cell signaling. Specifically, we demonstrate that
Nesca mobilizes from the cytoplasm to the nuclear envelope
in response to neurotrophin stimulation. The intracellular
redistribution of Nesca takes place gradually, increasing be-
tween 24–72 h of growth factor stimulation, and is coinci-
dent with increased serine phosphorylation. From overex-
pression and short interfering RNA (siRNA) studies in
PC12 cells, we also propose a possible function for Nesca
in regulating NGF-dependent neurite outgrowth. Collec-
tively, these data suggest that Nesca plays a role in neuronal
differentiation, specifically in signaling pathways that are
regulated by the prolonged activation of MAPK.
 
Results
 
Nesca translocates to the nucleus in response to NGF 
in neurotrophin-responsive cells
 
In our ongoing efforts to delineate the signal transduction
pathways mediated through trkA, we identified a poorly
characterized protein Nesca (Fig. 1 A; Matsuda et al.,
2000) in a yeast two-hybrid screen using the intracellular
domain of trkA as bait. As shown in Fig. 1 A, the molecu-
lar architecture of Nesca resembles a signaling adapter, sug-
gesting a potential role in signal transduction. Initially, we
Figure 1. Nesca localizes with the 
nuclear envelope in NGF-treated cells. 
(A) Schematic representation of Nesca. 
The RUN domain lies between 53D and 
197E. The leucine zipper (174L–202L), 
proline-rich region (203P–217P), putative 
WW domain (261W–284W), and the 
SH3 domain (382A–433L) are indicated. 
(B) Confocal analysis of EGFPNesca and 
RFP-trkA in nnr5 cells treated with 100 
ng/ml NGF for 72 h. Panels I and II show 
the intracellular distribution of RFP-trkA 
and EGFPNesca. Panel III reveals the 
association of NescaEGFP with the 
nuclear membrane. (C) The nuclear 
trafficking of Nesca was assessed over 
72 h of NGF treatment (100 ng/ml) in 
trkA-expressing B5 cells by fluorescence 
microscopy. The ratio of cells with 
nuclear rings relative to transfected cells 
was determined at 24, 48, and 72 h of 
NGF stimulation. (D) Subcellular fractions 
of B5 cells expressing EGFPNesca 
(    NGF) were prepared as described, 
and equal protein amounts were assayed 
by SDS-PAGE. Immunoblots were probed 
with an anti-EGFP antibody to localize 
EGFPNesca and with antibodies against 
actin, PCNA, and NUP98 as markers for 
cytoplasmic extracts, nuclear extracts, 
and the nuclear envelope, respectively. 
(E) Nesca mobilizes to the nuclear 
membrane after BDNF and NT-3 stimu-
lation (100 ng/ml, 4 d) of trkB- and trkC-
expressing nnr5 cells. 
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examined the subcellular localization of Nesca in NGF-
stimulated cells using confocal microscopy to determine if
EGFP-tagged Nesca colocalized with red fluorescent pro-
tein (RFP)–tagged trkA in the nnr5 cell line. Nnr5 cells
do not express trkA or respond to NGF, but transfection
with trkA reconstitutes their NGF-dependent neurite out-
growth. However, instead of a colocalization between
Nesca and trkA, we observed that Nesca localized primarily
to the nuclear envelope (Fig. 1 B) with a small amount at
the plasma membrane, whereas trkA was predominantly
located in the neurites (Fig. 1 B). Serial confocal images
suggest an association between Nesca and the nuclear
pores, the major proteinaceous component of the nuclear
envelope (Fig. 1 B, III; Mattaj and Englmeier, 1998). The
lack of colocalization, in conjunction with our inability to
coprecipitate trkA and Nesca (unpublished data), suggests
a lack of direct interaction between these proteins in NGF-
stimulated cells.
Despite the lack of interaction between trkA and Nesca,
the nuclear localization of Nesca in NGF-treated cells was
striking, and we examined this process in further detail.
Our results revealed the nuclear localization of Nesca to be
a dynamic process in that NGF stimulates a time-depen-
dent translocation of Nesca from the cytosol to the nuclear
envelope. The translocation process becomes readily appar-
ent only after 48 h (Fig. 1 C), and by 72 h, greater than
two-thirds of transfected cells displayed prominent nuclear
rings (Fig. 1 C). In contrast, we observed no Nesca nuclear
translocation in the absence of NGF, even after 96 h (Fig.
1 C). Cellular fractionation analysis confirmed the micro-
scopic data in that the bulk of Nesca localizes to the cytosol
in unstimulated cells, whereas NGF stimulates an increase
of Nesca in the nuclear membrane (Fig. 1 D). A small
amount of Nesca was also observed in the NGF-treated
nuclear extract (Fig. 1 D), suggesting the possibility that
Nesca may also be present in the soluble nucleoplasm. We
assessed the equivalence of protein loading by stripping
and reprobing with antibodies specific to proteins ex-
pressed in each fraction (Fig. 1 D). In contrast to trkA-
expressing nnr5 cells (B5), we observed no nuclear localiza-
tion of Nesca in nonneuronal HEK293 cells, even when
coexpressing trkA (unpublished data). The nuclear trans-
location of Nesca was unaffected by treatment with the
microtubule-disrupting agents nocodazole or colchicine (Wang
et al., 1998; Nusser et al., 2002), despite a complete col-
lapse of the neuritic network (unpublished data). These
data suggest that the nuclear translocation of Nesca is not a
passive process and is not dependent on the microtubule
network.
NGF is a member of the neurotrophin family of growth
factors that signal through a family of related trk receptors.
Thus, we determined if other neurotrophins, specifically
brain-derived neurotrophic factor (BDNF) and neurotro-
phin-3 (NT-3) also induced the nuclear translocation of
Nesca. Stable nnr5 lines expressing trkB and trkC were stim-
ulated with BDNF and NT-3, respectively, and assessed for
neurite outgrowth and the nuclear translocation of Nesca. In
both cases, both BDNF/trkB and NT-3/trkC stimulated the
nuclear redistribution of Nesca (Fig. 1 E) comparably to
NGF/trkA.
 
Nesca expression is highly enriched in the brain
 
Because we observed the neurotrophin-dependent nuclear
translocation of Nesca only in neuronal-like cells, we ad-
dressed the tissue distribution of Nesca expression. Previ-
ously, it had been reported that Nesca is expressed at equal
levels across a variety of human tissues (Matsuda et al.,
2000). However, we obtained a predominantly neuronal ex-
pression pattern upon probing human and murine multiple
tissue Northern blots (Fig. 2 A). Therefore, we performed
nonquantitative RT-PCR on a series of murine tissues using
primers directed against the mouse Nesca (655C-1552T) se-
quence obtained from the NCBI EST database (GenBank/
EMBL/DDBJ accession no. AK039664). Included in the
predicted 895 bp murine Nesca fragment is 175 bp of
3
 
 
 
UTR. Our results partially agree with previous results
(Matsuda et al., 2000) in that Nesca is expressed in some
nonneuronal tissues; however, we find a considerable enrich-
ment in brain (Fig. 2 B). At 20 cycles, Nesca was apparent
only in brain. In each case, the putative Nesca band was con-
firmed by sequence analysis. Glycerol-3-phosphate dehydro-
genase (GAPDH) served as a control (Fig. 2 B).
 
The nuclear translocation of Nesca is mediated through 
sequences contained in the amino terminus 
and occurs independently of an NLS
 
Many proteins that mobilize to the nucleus do so by means of
an NLS. Classically, two types of NLS have been described:
(1) a single stretch of 5–6 basic amino acids, and (2) a bipar-
Figure 2. Nesca is expressed primarily in the brain. (A) Multiple 
tissue Northern blots were probed with random primed Nesca-specific 
probes. (B) Total RNA was isolated from various murine tissues, and 
RT-PCR was performed as described in Materials and methods. 
GAPDH served as a control. 
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tite NLS consisting of 2 basic amino acids followed by a clus-
ter of 5 basic amino acids that are separated by a spacer region
of 
 
 
 
10 amino acids (Mattaj and Englmeier, 1998). Sequence
analysis of Nesca using PSORT (http://psort.nibb.ac.jp) failed
to reveal the presence of an NLS, although several basic amino
acid stretches are present (
 
10
 
QLQEQKK
 
16
 
, 
 
335
 
KSRR
 
338
 
, and
 
75
 
KPFRKDLITGQRR
 
87
 
). None of these sequences supported
the nuclear localization of a 
 
 
 
-Gal/EGFP fusion protein (Sorg
and Stamminger, 1999), comparable to the NLS of p53, or
enhanced the nuclear localization of EGFP alone, indicating
that they do not function as an NLS (unpublished data).
Consequently, we generated a series of carboxyl- and
amino-terminal deletion mutants to identify sequences im-
portant to the nuclear translocation. The 
 
 
 
SH3 mutant de-
letes amino acids 382A-433L and the 
 
 
 
257G-433L mutant
deletes the entire carboxyl terminus up to the WW domain
at 261W. This latter mutant retains the proline-rich region
between 203P and 217P and the leucine zipper between
174L and 202L. Both of these deletion mutants retained the
ability to translocate to the nucleus upon NGF stimulation
(compare Fig. 3, B and C, with Fig. 3 A). The amino-termi-
nal deletion mutants include 
 
 
 
52P-231G, deleting the entire
RUN domain and the leucine zipper, 
 
 
 
52P-166A deletes the
 
entire RUN domain and 
 
 
 
52P-86R deletes the first con-
served block of the RUN domain. In contrast to deletions at
the carboxyl terminus, deletions within the RUN domain
completely abrogated the translocation of Nesca, even after
5 d (compare Fig. 3, D–F, with Fig. 3 A). Point mutations
within the RUN domain had variable effects on the translo-
cation of Nesca. Alanine substitution of 78R and 79K had
no effect on the nuclear translocation of Nesca, whereas ala-
nine substitution of 70L had a deleterious effect (Fig. 3, G
and H). Leucine 70 constitutes an important conserved resi-
due within the first block comprising the structure of the
RUN domain, whereas 78R and 79K are not believed to play
specific roles as structural determinants (Callebaut et al.,
2001). No mutant underwent nuclear translocation in the
absence of NGF. These data indicate that the RUN domain
serves an essential role in the nuclear redistribution of Nesca.
 
Nesca is phosphorylated in response to NGF
 
The intracellular localization of many proteins is regulated by
their phosphorylation state; thus, we investigated if NGF in-
duces changes in the phosphorylation of Nesca. Previous re-
sults indicated that Nesca is not tyrosine phosphorylated (un-
published data), however, this did not exclude the possibility
that Nesca may be a target of a serine/threonine kinase(s) ac-
tivated in response to trkA. To address this issue, trkA-
expressing B5 cells were transfected with EGFP, EGFP-
Nesca, or HA-Nesca and incubated with NGF for 72 h, the
last 12 h of which included [
 
32
 
P]orthophosphate in phos-
phate/serum-free media. We selected a 72-h time point be-
cause the translocation of Nesca occurs maximally between
48 and 72 h (Fig. 1). Labeled cells were lysed and EGFP-
Nesca/HA-Nesca were immunoprecipitated and analyzed for
 
32
 
P incorporation and expression by Western blotting. As shown
in Fig. 4, a substantial increase in 
 
32
 
P incorporation in both
Figure 3. The RUN domain is essential for nuclear translocation. 
Nesca deletion and point mutants (EGFP tagged; A–H as indicated) 
were assessed for NGF-dependent (100 ng/ml NGF, 5 d) nuclear 
translocation in trkA-expressing B5 cells.
Figure 4. Nesca is phosphorylated in response to NGF. B5 cells 
were transfected with EGFPNesca or HA-Nesca ( /  100 ng/ml 
NGF, 72 h) or untransfected ( ). Cells were loaded with [
32P]ortho-
phosphate, washed, lysed, and immunoprecipitated with anti-EGFP 
or anti-HA antibodies. Immune complexes were separated by SDS-
PAGE and analyzed for 
32P incorporation and immunoblot analysis 
using 3F10 (anti-HA) or anti-EGFP antibodies. 
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EGFPNesca and HA-Nesca was observed in the presence of
NGF (Fig. 4, 
 
 
 
/
 
 
 
 NGF). We obtained identical results with
a myc-tagged Nesca construct (unpublished data). Densi-
tometry of 
 
32
 
P-labeled Nesca in Fig. 4, normalized to the
amount of EGFPNesca or HA-Nesca in each lane, revealed
an approximate sixfold increase in the phosphorylation state
of EGFPNesca in response to NGF and a fourfold increase in
the phosphorylation state of HA-Nesca. We detected no 
 
32
 
P
incorporation in EGFP alone (unpublished data). Phospho-
amino acid analysis of phospho-Nesca revealed only the pres-
ence of phosphoserine (unpublished data).
The aforementioned data confirms that the nuclear trans-
location and phosphorylation of Nesca occur coincidentally.
However, we wanted to determine the earliest point at which
Nesca is phosphorylated. Accordingly, B5 cells expressing
HA-tagged Nesca were labeled with [
 
32
 
P]orthophosphate and
stimulated with NGF for various times up to 24 h. No Nesca
phosphorylation was detected up to 24 h of NGF stimulation
(unpublished data), suggesting a correlation between Nesca’s
phosphorylation and its nuclear translocation.
 
Translocation of Nesca to the nucleus is growth 
factor specific and is dependent on prolonged 
MAPK activation
 
Because the neurotrophins comprise a closely related family
of growth factors eliciting similar cellular effects, we exam-
ined the effect of an unrelated growth factor, namely, EGF.
Although many of the same signaling proteins are acti-
vated upon stimulation with EGF and NGF (Wells, 1999;
Meakin, 2000), EGF does not induce cell cycle arrest or
neurite outgrowth in PC12 cells but rather elicits a prolifera-
tive response (Wells, 1999; Kao et al., 2001). A major differ-
ence between NGF and EGF signaling involves the activa-
tion of MAPK. In NGF-treated cells, the activation of
MAPK is prolonged, in contrast to the transient activation
in response to EGF (York et al., 1998; Kao et al., 2001). To
address this difference, B5 cells were cotransfected with
EGFPNesca and the EGF receptor (EGFR) and assayed for
both EGF-dependent nuclear translocation of Nesca and/or
the ability of Nesca overexpression to possibly facilitate the
ability of EGF to stimulate neurite outgrowth. As shown in
Fig. 5, EGF treatment greatly enhanced the EGFR phos-
phorylation but resulted in neither the induction of neurites
nor a change in the intracellular localization of Nesca (Fig.
5, A and B).
In a similar experiment, we analyzed the ability of trkA
mutants, unable to support NGF-dependent differentiation,
for their ability to promote the translocation of Nesca. TrkA
mutants designated trkAS3 (
 
 
 
493
 
IMENP
 
497
 
) and trkAS8
(Y
 
499
 
F) are impaired in their ability to bind Shc and FRS-2
(Stephens et al., 1994; Meakin and MacDonald, 1998;
Meakin et al., 1999). Despite being fully kinase active, nei-
ther mutant supports NGF-dependent neurite outgrowth
(Meakin and MacDonald, 1998; Meakin et al., 1999) and
both are impaired in their ability to activate MAPK when as-
sayed at comparable levels of receptor expression relative to
wild-type trkA (Meakin and MacDonald, 1998; Meakin,
2000). Not surprisingly, these mutants are incapable of sup-
porting the NGF-dependent nuclear translocation of Nesca
(Fig. 5 C). Two other trkA mutants, trkAS9 (Y
 
794
 
F) and
trkAT1 (
 
 
 
787
 
L-G
 
799
 
), were assessed for their ability to sup-
port the nuclear translocation of Nesca. Neither mutant
binds PLC
 
 
 
-1 or CHK (Stephens et al., 1994; Yamashita et
al., 1999); however, both support NGF-dependent neurite
outgrowth and the nuclear translocation of Nesca. These
data indicate that the mobilization of Nesca is independent
of PLC
 
 
 
-1 or CHK (Fig. 5 B).
The aforementioned data indicates a link between Nesca
translocation and the prolonged activation of MAPK. Pur-
suant to this, we mimicked the effects of NGF by activat-
ing MAPK with a constitutively active MKK1 construct
(R4F; Emrick et al., 2001). Thus, differentiation in the ab-
sence of trk activation was obtained. As expected, B5 cells
transfected with MKK1R4F extended neurites (Fig. 6, A
and B). Moreover, when coexpressing EGFPNesca, neurite
extension was coincident with a translocation of Nesca to
the nucleus (Fig. 6 A). In a similar experiment, we inhib-
ited MAPK with the selective MKK1/MKK2 inhibitor
UO126 (Favata et al., 1998). Neurotrophin-responsive B5
Figure 5. Nesca does not translocate to the nucleus in response 
to EGF or after activation of trkA mutants incapable of supporting 
neurite outgrowth. B5 cells were cotransfected with EGFPNesca 
and the EGFR and stimulated with 100 ng/ml EGF for 72 h to assess 
EGFR activation (A) and cell phenotype/nuclear rings (B). (C) Nnr5 
cells expressing the trkA mutants trkAS3 ( 
493IMENP
497), trkAS8 (Y
499F), 
trkAS9 (Y
794F), and trkA-T1 ( 
787L-G
799) were transfected with 
EGFPNesca and stimulated with 100 ng/ml NGF for 5 d. 
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cells expressing EGFPNesca were incubated with 10 
 
 
 
g/ml
U0126 before stimulation with 100 ng/ml NGF. Cells
treated with U0126 and NGF displayed considerably
smaller, less developed neurites relative to controls (unpub-
lished data). Coincident with the lack of neurite develop-
ment, we observed a significant decrease in the nuclear
translocation of Nesca in the U0126-treated cells (Fig. 6
C). Moreover, we found that treatment of B5 cells with
U0126 also led to an inhibition of NGF-dependent phos-
phorylation of Nesca (Fig. 6 D). Although Nesca contains
several potential MAPK phosphorylation sites, we have not
been able to show Nesca to be a substrate of MAPK in
vitro. Alternatively, Nesca may be phosphorylated by a ki-
nase activated downstream of MAPK in the neurotrophin
signaling pathway.
Although the nuclear translocation of Nesca is dependent
on the prolonged activation of MAPK, we determined if
Nesca is phosphorylated in the absence of translocation. Ac-
cordingly, we compared the incorporation of [
 
32
 
P]phosphate
in EGFPNesca and the EGFPNesca L70A mutant incapable
of undergoing NGF-dependent nuclear translocation (Fig. 3
G). Surprisingly, we found that the wild type and L70A mu-
tant were phosphorylated to similar levels (Fig. 6 E). Thus,
although prolonged activation of MAPK is essential to the
nuclear translocation of Nesca, phosphorylation appears to
precede nuclear translocation.
 
Nesca potentiates neurite outgrowth in PC12 cells
 
It has been suggested that RUN domains function in Ras-
like GTPase signaling (Callebaut et al., 2001). Because
Nesca contains a RUN domain and may play a role in
small GTPase signaling, we determined the effects of
Nesca overexpression on NGF-dependent PC12 cell differ-
entiation. Stable PC12 cell lines overexpressing EGFP-
Nesca and EGFP alone were generated and, as overexpres-
sion of Nesca alone induced no discernible phenotype, we
assayed for phenotypic changes in response to NGF. As
shown in Fig. 7 A, neurite outgrowth in PC12 cells ex-
pressing EGFPNesca after a 48-h incubation with 20 ng/
ml NGF was consistently more robust than that observed
in the EGFP-expressing controls. The cells were divided
into three categories and the degree of neurite extension
was quantified, the results of which are shown in Fig. 7 B.
After 48 h with NGF, all Nesca-overexpressing clones dis-
Figure 6. The nuclear translocation of Nesca is 
stimulated by constitutively active MKK1 and is 
dependent on prolonged MAPK activation. (A) The 
nuclear translocation of Nesca was assessed in B5 
cells coexpressing EGFPNesca and a constitutively 
active MKK1 (R4F; Emrick et al., 2001). (B) The nuclear 
translocation of Nesca was determined as the ratio of 
total transfected cells containing nuclear rings after 48 h. 
The error bars represent the SD from the mean. Statistical 
significance (*, P   0.001) of neurite induction by 
MKK1 R4F relative to the control was determined 
using t test. (C) B5 cells expressing EGFPNesca were 
stimulated with NGF for 48 h in the presence and 
absence of the MKK1 inhibitor U0126 (10  M). 
Quantitation (right) was performed as described in B. 
The error bars represent the SD from the mean. (D) Cells 
were labeled with [
32P]orthophosphate and analyzed 
for [
32P]phosphate incorporation. The control represents 
untransfected cells.  The bottom panel shows the 
expression levels of EGFPNesca. (E) B5 cells expressing 
the L70A Nesca mutant and/or wild-type Nesca were 
loaded with [
32P]orthophosphate and analyzed for 
[
32P]phosphate incorporation. 
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played significantly more neurites with a neurite/cell body
length ratio of 
 
 
 
2 (Fig. 7 B, I). In addition, the Nesca-
overexpressing lines displayed more neurites with a neu-
rite/cell body ratio of 1–2 relative to controls (Fig. 7 B, II).
Conversely, the number of cells with a neurite/cell body
length ratio of 
 
 
 
1 was consistently higher in the EGFP-
expressing clones (Fig. 7 B, III). Levels of EGFP and
EGFPNesca expression in each of the clones was relatively
comparable, except in NescaD2, as shown in Fig. 7 C.
Although compelling, the data outlined here do not
firmly establish a role for Nesca in neurotrophin-depen-
dent neurite outgrowth. Therefore, we used several addi-
tional strategies. First, we determined whether nuclear
translocation of Nesca is essential to its neurite outgrowth-
promoting properties by taking advantage of the L70A
Nesca mutant, incapable of nuclear translocation. We gen-
erated PC12 cell clones overexpressing L70A and assayed
NGF-dependent neurite outgrowth relative to EGFP- and
EGFPNesca (wild type)-expressing cell lines. Four EGFP-
L70A cell lines and a single additional wild-type–overex-
pressing cell line were analyzed under conditions identical
to those described for Fig. 7. In each case, NGF-dependent
neurite outgrowth was less robust in the L70A lines com-
pared with wild-type Nesca (Fig. 8 A). Approximately 20%
of the wild-type Nesca-overexpressing cells displayed neu-
rites of 2 soma diameters, whereas none of the L70A
Nesca-overexpressing cells had neurites 
 
 
 
1 soma diameter
after 48 h of NGF (unpublished data). All cell lines dis-
played similar levels of Nesca expression (Fig. 8 A).
In a corollary experiment, we used an EGFP siRNA oligo-
nucleotide (Hannon, 2002) to silence EGFPNesca in the EGF-
PNesca-overexpressing D2 cell line (Fig. 7) and compared
neurite outgrowth relative to the parental D2 line and PC12
cells. After 48-h incubation with 20ng/ml NGF, neurite out-
growth in the D2 knockdown cell lines (A5 and A6) was sig-
nificantly reduced relative to the parental D2 line and was
comparable to PC12 cells (Fig. 8 B). Western blot analysis for
EGFP clearly shows a reduction of EGFPNesca expression in
the A5 and A6 cell lines (Fig. 8 B). Subsequent analysis of two
other D2 knockdown cell lines revealed identical results to
those described in Fig. 8 B (unpublished data).
Finally, we reduced the expression of endogenous Nesca
in PC12 cells using specific siRNA oligonucleotides homol-
ogous to rat Nesca. Stable clones expressing the siRNAs
were analyzed for Nesca expression by Western blotting as
well as for their effects on NGF-induced neurite outgrowth
(10 ng/ml NGF, 5 d). Although we observed no neurites 
 
 
 
2
cell bodies in the knockdown cell lines comparable to paren-
tal PC12 cells, neurite outgrowth was not completely abro-
gated (Fig. 8 C). This residual neurite outgrowth is probably
a result of our inability to completely eliminate endogenous
Nesca expression (Fig. 8 C). Collectively, these data strongly
suggest a role for Nesca in the regulation of neurite out-
growth in NGF-treated PC12 cells.
Figure 7. Nesca potentiates neurite outgrowth in 
NGF-treated PC12 cells. (A) EGFP-expressing PC12 
cells (A1, A5I, and A5II) and EGFPNesca-expressing 
lines (C1, C4, D2, and D3) were stimulated with 20 
ng/ml NGF for 48 h and assessed for neurite extension. 
(B) Quantification of neurite outgrowth: cells with a 
neurite to cell body length ratio of  2 (I); cells with 
a neurite to cell body length ratio of 1–2 (II); and cells 
with a neurite to cell body length ratio of  1 (III). 10 
random fields were counted for each cell line in each 
experiment (n   3). The error bars represent the SD 
from the mean. (C) Expression of EGFP and EGFPNesca 
was assessed by immunoblotting using 10 and 50  g 
of total lysate from each cell line. 
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Overexpression of Nesca prolongs the activation state 
of MAPK
 
As stated earlier, the prolonged activation of MAPK is a
strong correlate of differentiative signaling, as opposed to
the transient kinetics of activation during proliferation.
Therefore, it was of interest to determine if Nesca overex-
pression had any effect on the kinetics of NGF-induced
phosphoMAPK. Cell lines overexpressing wild-type EGFP-
Nesca were stimulated with NGF for varying lengths of
time, under serum starvation, and analyzed for active ERK1/
ERK2 by Western blotting. As shown in Fig. 9 A, PC12 cell
lines overexpressing Nesca (C1, C4, D2, and D3) maintain
levels of phosphoERK1/ERK2 at higher absolute levels at 24
and 48 h relative to lines expressing EGFP alone (
 
n
 
 
 
  
 
4).
We also analyzed the D2 EGFPNesca knockdown cell
lines for MAPK activation after 72 h stimulation with NGF.
In each of the four D2 knockdown lines examined, the level
of phospho-MAPK after 72 h approximated that observed
for PC12 cells and was considerably lower than that ob-
served for the parental D2 Nesca-overexpressing cell line
(Fig. 9 B). Stripping and reprobing the blot with an anti-
MAPK antibody revealed equal levels of kinase (Fig. 9 B).
 
Discussion
 
In addition to signaling proteins recruited directly to trkA
(Meakin, 2000; Huang and Reichardt, 2003), many mole-
cules function downstream in response to NGF stimulation.
Included amongst these downstream targets are MAPK,
Rac1 (Yasui et al., 2001), cdc42 (Chen et al., 1999), and the
myotonic dystrophy kinase-related cdc42 binding kinase
MRCK
 
 
 
 and 
 
 
 
 (Chen et al., 1999), which are involved in
regulating cytoskeletal changes necessary for neurite out-
growth.
To reconstitute the pathways involved in trkA-mediated
differentiation, it is necessary to identify the proteins that act
downstream of an active receptor complex. Here, we de-
scribe the translocation of Nesca, a novel signaling adapter,
from the cytosol to the nuclear envelope in response to neu-
rotrophin stimulation. Several lines of evidence indicate that
the nuclear translocation of Nesca is dependent on the pro-
longed activation of MAPK, a hallmark of the differentiative
response (Marshall, 1995; York et al., 1998). First, Nesca
does not translocate in response to EGF or in cells express-
ing trkA receptor mutants (trkAS3 and trkAS8) incapable of
supporting NGF-dependent cell cycle arrest or neurite out-
growth. Activation of the EGFR results in only transient ac-
tivation of MAPK (Kao et al., 2001), whereas the trkAS3
and trkAS8 mutants impair Shc and FRS2 recruitment and
can activate MAPK only fractionally relative to wild-type
trkA (Meakin and MacDonald, 1998; Meakin, 2000). In
combination, the current data points to the importance of
either the FRS2 or Shc adapters in the trk-dependent mech-
anisms regulating the nuclear translocation of Nesca. Sec-
ond, Nesca translocates to the nucleus in the absence of
NGF when MAPK is constitutively activated; and third, the
nuclear translocation of Nesca is abrogated in the presence
of NGF when the MAPK pathway is inhibited with U0126.
Figure 8. Overexpression of the L70A Nesca mutant 
and/or loss of endogenous Nesca expression negatively 
affects NGF-dependent neurite outgrowth. (A) PC12 
cell lines stably expressing the nuclear translocation 
defective L70A Nesca mutant were assayed for neurite 
outgrowth (20 ng/ml NGF; 48 h). (B) EGFPNesca 
expression was silenced in PC12 EGFPNesca D2 cells 
with the pSilencer vector expressing a siRNA targeted 
against EGFP. Clones were analyzed for NGF-dependent 
neurite outgrowth and Nesca expression by Western 
blotting. Antityrosine hydroxylase antibodies served 
as a control for protein loading. (C) Endogenous Nesca 
expression was silenced in stable PC12 cells as 
described in Materials and methods. Cells were treated 
for up to five days with 10 ng/ml NGF. Control PC12 
cells expressed a scrambled siRNA with no homology 
to rat mouse or human genomic sequences. Changes 
in endogenous Nesca expression were determined 
with an affinity-purified mouse anti-Nesca antibody. 
Left lane represents murine Nesca expressed in 
HEK293 cells. 
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Although we do not yet fully understand the mechanism
underlying the neurotrophin-dependent nuclear redistribu-
tion of Nesca, it is clear that the process is dependent on the
structural integrity of the RUN domain. Specifically, a sin-
gle point mutation, L70A, predicted to be integral to the
structure of the RUN domain (Fig. 3 G), abrogates the nu-
clear localization of Nesca. Although the function of RUN
domains is not clear, many RUN domain–containing pro-
teins are involved in signaling by members of the Ras super-
family of small GTPases, including members of the Rap and
Rab families (Janoueix-Lerosey et al., 1998; Callebaut et al.,
2001; Mari et al., 2001; Yang et al., 2002). Whether or not
Nesca interacts with and/or regulates cytoplasmic/nuclear
transport mediated through the Ran GTPase is the subject
of ongoing investigations.
Because Nesca does not contain a nuclear translocation se-
quence, the question is raised as to the underlying mecha-
nism by which Nesca translocates to the nucleus. An obvi-
ous starting point involves the kinetics of NGF-dependent
phosphorylation of Nesca that correlates with the kinetics of
translocation (
 
 
 
24 h of NGF treatment). Thus, it may be
postulated that phosphorylation-dependent changes in pro-
tein–protein interactions govern the intracellular localiza-
tion of Nesca. Interestingly, the intracellular localization of
the MAPKs is also determined by changes in protein–pro-
tein interactions that are ultimately determined by changes
in protein phosphorylation. In their inactive form, the
MAPKs are cytoplasmic and are tethered to the MEKs and
MAPK phosphatase-3 (Cyert, 2001; Robinson et al., 2002).
Upon activation, the MAPKs are phosphorylated and re-
leased from their cytoplasmic tethers, and, after dimeriza-
tion, they translocate to the nucleus (Cyert, 2001; White-
hurst et al., 2002). However, having made this analogy, the
L70A Nesca mutant still undergoes NGF-dependent phos-
phorylation, despite not undergoing nuclear translocation,
raising the possibility that the translocation of Nesca in-
volves a binding partner. Essentially, phosphorylation ap-
pears to precede translocation, and sequences within the
RUN domain are involved in either the translocation pro-
cess itself or in retention at the nuclear envelope. In addi-
tion, the temporal regulation of phosphorylation and nu-
clear translocation of Nesca raises the possibility that the
process may depend on the synthesis of a chaperone protein
and/or kinase. However, attempts to address this possibility
by inhibiting protein synthesis with cycloheximide have
been difficult to interpret due to the long incubation times
required to observe Nesca’s redistribution coupled with the
cytotoxicity of the drug.
Currently, we have no information regarding the nature
of the kinase(s) responsible for Nesca phosphorylation, and
we have not been able to demonstrate direct in vitro phos-
phorylation of Nesca by MAPK itself. The rapid activation
of MAPK, coupled with the fact that Nesca is not phosphor-
ylated until after 24-h NGF stimulation, provides an argu-
ment against Nesca being a direct target of MAPK. Rather,
the data suggest that Nesca may be phosphorylated by an
unidentified kinase activated downstream of, or transcrip-
tionally regulated by, MAPK itself. Consensus phosphoryla-
tion sites for cAMP-dependent kinase, PKA, calmodulin-
dependent protein kinase II, and PKC exist in Nesca.
Whether or not any of these kinases contribute to the phos-
phoserine content of NGF-stimulated Nesca is the subject of
ongoing investigations. Obviously, the identification of the
site(s) of Nesca phosphorylation would benefit our under-
standing of the mechanism of nuclear translocation and aid
in the overall understanding of trk-mediated signaling.
The enhancement of neurite outgrowth in PC12 cells
overexpressing Nesca, and the reduction in process forma-
tion in siRNA knockdown cells, suggests a functional role
for Nesca in NGF signaling, although the nature of this role
is not yet clear. Cytoskeletal rearrangements, necessary for
neurite outgrowth, are regulated through members of the
Rho subfamily of the Ras superfamily of small GTPases. In
PC12 cells, Rac1 regulates neurite outgrowth (Chen et al.,
1999; Yasui et al., 2001; Nusser et al., 2002) through a
mechanism that involves Ras and PI-3 kinase (Yasui et al.,
2001). Moreover, RhoA, which negatively affects neurite
outgrowth, is inactivated in a process that involves a change
in its intracellular localization (Nusser et al., 2002). Al-
though the kinetics of RhoA inactivation make it unlikely
that Nesca plays a role in this process, Nesca may enhance
the activity of Rac and/or cdc42.
Alternatively, Nesca may indirectly influence neurite
outgrowth by amplifying trk-mediated signaling pathways,
perhaps by prolonging activation in NGF-induced signal-
ing endosomes (Wu et al., 2001). RUN domain–contain-
Figure 9. Nesca overexpression in NGF-treated PC12 cells results 
in enhanced levels of activated MAPK. (A) PC12 cell lines stably 
expressing EGFP and EGFPNesca and (B) EGFP knockdown cell lines 
(A2, A4, A5, and A6) derived from the EGFPNesca D2 line were serum 
starved for 24 h followed by the addition of 20 ng/ml NGF for varying 
lengths of time or for 72 h (EGFPNesca D2 knockdowns). Lysates 
were analyzed for phosphoMAPK, and the blots were stripped and 
reprobed with a MAPK antibody to assess protein loading. 
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ing proteins have been shown to promote endosomal fu-
sion (Mari et al., 2001). However, having said this, the
appearance of NGF-induced signaling endosomes is rapid
(Wu et al., 2001), whereas the appearance of Nesca at the
nucleus is a comparatively slow process. Thus, if Nesca
does have a role in endosomal fusion, it would be confined
to late signaling endosomes.
It is also possible that Nesca could differentially regulate
nuclear trafficking and, in so doing, regulate mechanisms of
transcription and/or translation in response to neurotrophin
stimulation. It is also possible that Nesca plays multiple roles
in trk-mediated signaling. The existence of a small subsidiary
pool of Nesca at the plasma membrane in NGF-treated
nnr5-B5 cells is alluded to by confocal microscopy (Fig. 1 B,
I and II) and biochemical analyses. This secondary pool may
function in a stimulatory role for plasma membrane–bound
small GTPases involved in neurite outgrowth as discussed
earlier in this section. Insofar as neurite outgrowth represents
a phenotypic measure of neurotrophin-dependent differenti-
ation, we can only conclude at this point that the evidence
indicates that Nesca regulates some aspect of development,
the final measure of which is process formation.
At present, we cannot rule out an intranuclear role for
Nesca. Clearly, the confocal images reveal little Nesca within
the nucleus. However, as stated earlier, cellular subfraction-
ation studies show a small amount of Nesca within the nu-
clear extracts of NGF-treated nnr5-B5 cells. If the primary
site of Nesca activity is within the nucleus, then the mass of
Nesca found on the nuclear periphery may simply represent
protein congregating at the nuclear envelope before trans-
port. Conversely, it is possible that this intranuclear Nesca
simply represents a contaminant in the nuclear extract frac-
tion originating from the nuclear envelope. We are directing
future efforts at distinguishing between these models by
identifying proteins and/or RNAs that may bind to Nesca in
order to understand more fully the role of Nesca in neu-
rotrophin-dependent signaling.
 
Materials and methods
 
Materials
 
All primary antibodies, except the anti-myc antibody 9E10 and the pan-trk
antibody 203, were obtained from Roche Molecular Biochemicals (anti-
HA: 12CA5 or 3F10). Other primary antibodies used were EGFR and GFP
(Santa Cruz Biotechnology, Inc.), phospho-p44/42 MapK (New England
Biolabs, Inc.), Erk2 (BD Biosciences), and RC20 (Transduction Laborato-
ries). The secondary antibodies, HRP-goat anti–mouse and HRP-goat anti–
rabbit, were obtained from Jackson ImmunoResearch Laboratories. 
 
 
 
-NGF
and EGF were obtained from Harlan Products for Bioscience. BDNF and
NT-3 were provided by A.A. Welcher (Amgen Inc., Thousand Oaks, CA).
A polyclonal anti-Nesca antibody was generated against the peptide
 
323
 
CPSETESGAFKSRRP
 
337
 
 of mouse Nesca by Gen-Med Synthesis. The anti-
body was affinity purified by passage over a peptide affinity column gener-
ated by coupling the Nesca peptide to NHS-activated Sepharose (Amer-
sham Biosciences). The constitutively active MKK1 mutant (R4F; Emrick et
al., 2001) was the gift of N. Ahn (University of Colorado, Boulder, CO).
The siRNA plasmid pSilencer 3.1H-1 Hygro was obtained from Ambion.
The vector pSuper was a gift of R. Agami (The Netherlands Cancer Insti-
tute, Amsterdam, Netherlands; Brummelkamp et al., 2002).
 
Plasmids and constructs
 
The amino terminal HA-epitope (YPYDVPDYASL) tagged Nesca was
cloned into the mammalian expression vector pcDNA3.1 (Invitrogen),
whereas a carboxyl-terminal myc-epitope tagged Nesca was prepared in
pcDNAMycHis (Invitrogen). The EGFP-Nesca fusion protein and all subse-
quent Nesca mutants were constructed in pEGFPN3 (CLONTECH Labora-
tories, Inc.). The RFP-trkA fusion protein was constructed in pDsRedN1
(CLONTECH Laboratories, Inc.). A cDNA encoding the human EGFR in
the expression vector pRK5 was obtained from M. Moran (Samuel Lunen-
feld Research Institute, Toronto, Canada). The Nesca deletion mutants
 
 52P-231G,  52P-166A, and  52P-86R were generated by PCR-mediated
introduction of an XbaI site at the indicated amino acid junctions (e.g., 52P
and 231G) in EGFPNesca, followed by digestion with XbaI and re-ligation.
The carboxyl-terminal deletions ( 382A-433L and  257A-433L) and sin-
gle site Nesca mutants (L70A and R78A:K79A) were generated by PCR us-
ing standard procedures.  All PCR reactions used to generate constructs
employed Herculase-enhanced DNA polymerase (Stratagene), and all
products were sequenced completely to ensure fidelity. The siRNA se-
quence GGTTATGTACAGGAACGCA directed against EGFP (Ambion)
was cloned into the vector pSilencer (Ambion). For Nesca silencing,
two 19-mer oligonucleotides, 
112GCTTGGTTCAGAAAGCTCAA
131 and
295ACCAGGTTCCTGCACACATT
314, homologous to rat Nesca, were se-
lected. The former oligonucleotide was cloned into the pSuper plasmid
(Brummelkamp et al., 2002) that was modified by the addition of a zeocin
resistance marker (pSuperZeo). The latter oligonucleotide was cloned into
the pSilencer vector (hygromycin resistant). Cells were transfected using Li-
pofectamine 2000 (Invitrogen) at a 2:1 ratio of LF2000/DNA and selected
with zeo and hygromycin.
Cell culture
PC12 cells expressing EGFP (clones A1, A5I, and A5II), EGFPNesca (clones
C1, C4, D2, and D3), and EGFPNescaL70A (clones C1, C6, D3, and D6)
and nnr5 cells expressing HA-tagged trk receptors (trkA[B5], trkB[B5],
trkC[C3], trkAS8 [Y499F], trkAS3 [ 
493IMENP
497], trkAS9 [Y794F], and
trkAT1 [ 
787L-G
799]) were generated as described previously (Meakin and
MacDonald, 1998; Meakin, 2000). HEK293 cells were maintained in DME
supplemented with 10% FBS (Hyclone). EGFPNesca knockdowns (clones
A5 and A6) were generated by transfecting PC12 EGFPNesca expressing
D2 cells with pSilencer expressing a siRNA against EGFP, selected with
500  g/ml hygromycin and maintained in 50  g/ml hygromycin. We gen-
erated PC12 lines with loss of endogenous Nesca (clones 1-6, 2-1, 2-3,
and 3-1) by cotransfecting cells with pSuperNesca112 and pSilencer-
Nesca295 and selecting with 400  g/ml zeocin and 500  g/ml hygromy-
cin. Cells were maintained in 100  g/ml zeocin and 50  g/ml hygromy-
cin. Negative control PC12 cells were generated by transfecting cells with
pSilencer containing a scrambled siRNA oligonucleotide with no homol-
ogy to mouse, human, or rat sequences (Ambion).
Microscopy and image processing
For confocal microscopy, nnr5 cells were transfected with 2.5  g each of
pEGFPN3Nesca and pDsRedN1HA-trkA as described in the previous para-
graph, grown overnight, and seeded onto poly-D-lysine–coated coverslips
in 35-mm culture dishes and stimulated with 100 ng/ml NGF (72 h). Cells
were washed with PBS, fixed in 4% PFA (15 min, RT), washed and
mounted on glass slides under PBS, and visualized with a confocal micro-
scope (model LSM 510; Carl Zeiss MicroImaging, Inc.). For epifluores-
cence microscopy, cells were visualized for EGFP and RFP using appropri-
ate filter sets (B-3A [excitation of 420nm, barrier of 520nm] and G-2A
[excitation of 510 nm, barrier of 590 nm]) on inverted microscopes (1  
70 [Olympus]; Diaphot 300 [Nikon]) at a magnification of 200–600.
Phase-contrast images were visualized with a magnification of 200 using
an inverted microscope (model Diaphot 300; Nikon). All images were cap-
tured with digital cameras (model Pro-series 3CCD) using Image-Pro soft-
ware. Images were processed in Adobe Photoshop 7.0 and imported into
CorelDraw (version 11) for figure presentation.
RT-PCR and Northern analysis
RNA was isolated using Trizol (Invitrogen) and cDNA was transcribed us-
ing Superscript (Invitrogen). RT-PCR was performed with primers specific
to mouse Nesca (5 -CCTGGACCTGCTCTTTGAGCAC-3  and 5 -CAG-
ATTTCACCTCACAGGTGGG-3 ) and GAPDH (5 -CTCAACTACATG-
GTYTACATGTTCC-3  and 5 -ATGGACTGTGGTCATGAGYCCTTCC-3 ).
Multiple tissue Northern blots (CLONTECH Laboratories, Inc.) were
probed with 
32P-dCTP–labeled probes corresponding to a carboxyl-termi-
nal sequence (822C-1424G) of mouse Nesca or nucleotides 1736T–1885T
of the 3 -UTR of human Nesca (Matsuda et al., 2000).
Immunoprecipitations and immunoblotting
Immunoprecipitations were performed as described previously (Meakin
and MacDonald, 1998). In brief, cells were washed with ice-cold PBS con-
taining 10 mM NaF and 1 mM vanadate before being lysed in NP-40 lysisNesca, a novel neurotrophin signaling adapter | MacDonald et al. 861
buffer (Meakin and MacDonald, 1998) containing 10  g/ml aprotinin, 10
 g/ml leupeptin, 1 mM vanadate, 10 mM NaF, and 1 mM PMSF. Immune
complexes were precipitated by the addition of Gamma Bind Plus (Amer-
sham Biosciences) and Pansorbin (rabbit specific; Calbiochem) or Tachi-
sorb (mouse specific; Calbiochem). The immune complexes were ana-
lyzed by SDS-PAGE and Western blots as described previously (Meakin
and MacDonald, 1998). Blots were stripped for reprobing in 62.5 mM Tris-
Cl, pH 6.8, 1% SDS, and 100 mM  -mercaptoethanol at 50 C for 15 min.
Antibodies for Western blotting were used at the following dilutions: phos-
pho-Mapk, 1:2500; Erk2, 1:2000, GFP, 1:1000; RC20, 1:2500.
Subcellular fractionation
Nnr5-B5 cells were transfected with EGFPNesca and stimulated with NGF
for 72 h. The cells were washed with ice-cold PBS and lysed in 10 mM
Tris-HCl, 3 mM MgCl2, 10 mM NaCl, 5 mM EGTA, 0.05% NP-40, 5 mM
NaF, 1 mM vanadate, and protease inhibitors, pH 7.5. After centrifugation
(400 g), the nuclear pellet was washed twice with lysis buffer and twice
with nuclear wash buffer (10 mM Hepes, 300 mM sucrose, 3 mM MgCl2,
25 mM NaCl, 1 mM EGTA, 5 mM NaF, 1 mM vanadate, and protease in-
hibitors, pH 6.8). Supernates were pooled and centrifuged at 100,000 g to
obtain the cytosolic fraction. The pellet was resuspended in nuclear wash
buffer containing 0.5% Triton X-100, incubated on ice for 5 min, and cen-
trifuged at 700 g to separate nucleoplasm from nuclear membranes. The
nuclear membrane was resuspended in nuclear wash buffer.
In vivo phosphorylation study
The phosphorylation state of Nesca was analyzed by in vivo labeling with
[
32P]orthophosphate of nnr5-trkA B5 cells transfected with EGFPNesca or
HA-Nesca and stimulated with NGF. In brief, cells were plated in a 6-well
plate, transfected with EGFPNesca, HA-Nesca, or EGFP, and then left un-
treated or stimulated with 100 ng/ml NGF (72 h) to generate nuclear rings
in  75% of cells. The media were replaced with serum/phosphate-free
DME and NGF, where applicable, and the cells further incubated for 2 h
followed by the addition of 0.1 mCi/ml [
32P]orthophosphate for 12 h. The
cells were washed and lysed, and EGFPNesca or EGFP were immunopre-
cipitated with a monoclonal anti-GFP antibody (1–2  g antibody/IP) or
HA-Nesca with 12CA5. Immune complexes were collected, analyzed by
SDS-PAGE, and exposed to X-ray film for visualization. To localize EGFP-
Nesca or HA-Nesca, the blots were probed with the anti-EGFP antibody or
3F10. Radiolabeled EGFPNesca was excised and Cherenkov radioactivity
determined. Phosphoamino acid analysis was performed as described pre-
viously (Kamps, 1991), and phosphoamino acids were separated by thin-
layer electrophoresis on cellulose plates (Boyle et al., 1991).
Identification of Nesca
Nesca was isolated in a yeast two-hybrid screen using the intracellular do-
main of rat trkA as bait. The yeast two-hybrid screen was performed using
the yeast strain PJ694A as described previously (MacDonald et al., 1999)
using commercially available human fetal brain and mammary libraries
(CLONTECH Laboratories, Inc.).
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